Hi, what are you looking for?
Company appoints former big tobacco executive Miguel Martin as chief commercial officer
Company continues corporate reset as Booth makes final exit
Cannabis giant makes second round of aggressive cuts as industry continues to downsize amid headwinds
US$40M acquisition of Reliva gives Aurora the No. 2 US CBD brand by market share
The mega-producer's valuation rose almost 70% on the day but is still a far-cry from where many bought in
Company board approves 1-for-12 share consolidation plan in attempt to remain listed on NYSE
Things go from bad to worse for what was once one on Canada’s most promising producers
The pot giant announced a third-quarter net loss of $1.3 billion and a 27 per cent decline in cannabis sales
Three out of 10 Canadian facilities are now EU GMP certified
Aurora Cannabis, HEXO and Sundial are facing class-action lawsuits for making misleading claims to investors